Is Aarti Industries Ltd (AARTIIND) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Industries Ltd is a good quality company .

Is Aarti Industries Ltd (AARTIIND) undervalued or overvalued?

The key valuation ratios of Aarti Industries Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Aarti Industries Ltd (AARTIIND) share price return in the past 10 years?

Aarti Industries Ltd share price has appreciated 12.5% annually (CAGR) over the past ten years.

Is Aarti Industries Ltd (AARTIIND) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aarti Industries Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Aarti Industries Ltd (AARTIIND)?

Company share prices are keep on changing according to the market conditions. The current trading price of Aarti Industries Ltd (AARTIIND) on 17-Apr-2026 16:59:59 at 16:59 is 440.70.

What is the P/E ratio of Aarti Industries?

The latest standalone P/E ratio of Aarti Industries as of 17-Apr-2026 is 42.61.

What is the P/B ratio of Aarti Industries Ltd (AARTIIND)?

The latest standalone P/B ratio of Aarti Industries Ltd (AARTIIND) as of 17-Apr-2026 is 2.73.

What is the 52-week high and low of Aarti Industries Ltd (AARTIIND)?

The 52-week high of Aarti Industries Ltd (AARTIIND) is Rs. 494.00 and the 52-week low is Rs. 338.20.

Aarti Industries Ltd (AARTIIND) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Aarti Industries Ltd (AARTIIND)
Brand: Aarti Industries

Aarti Industries Ltd (AARTIIND) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524208 NSE: AARTIIND | Chemicals | Small Cap

Aarti Industries Ltd (AARTIIND)

BSE: 524208 NSE: AARTIIND

Key Metrics

Market Cap

₹15,980 Cr.

P/E Ratio

42.27

Price to Book (P/B)

2.73

Price to Sales (P/S)

1.99

EV/EBITDA

17.99

Return on Capital Employed (ROCE)

6.39%

Current Price

₹440.7

Return on Equity (ROE)

6.08%

Return on Assets (ROA)

3.17%

Operating Profit Margin

13.8%

Net Profit Margin

4.55%

Gross Profit Margin

9.2%

Book Value per Share

₹161.2

Sales Growth (YoY)

14.14%

Sales Growth (3 Years)

6.11%

Operating Profit Growth (1 Year)

2.35%

Operating Profit Growth (3 Years)

-16.62%

Net Profit Growth (1 Year)

-20.55%

52-Week Low / High

₹338 / 494

Net Profit Growth (3 Years)

-34.66%

Dividend Yield

0.26%

Promoter Holding

42.09%

Pledged shares (%)
of Promoter's holding (%)

3.57%

Check Before You Invest

Q.1 Revenue growth of Aarti Industries Ltd?

Aarti Industries Ltd revenue growth is 14.1% for FY-2025 , which is above its 5 year CAGR of 11.7% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Aarti Industries Ltd?

Promoters hold 42.14% of the Aarti Industries Ltd, with 3.57% of their stake pledged, indicating low pledge risk.

Q.1 Revenue growth of Aarti Industries Ltd vs industry peers?

Aarti Industries Ltd revenue CAGR is 11.68% , compared to the industry median CAGR of 7.7% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Aarti Industries Ltd belong to?

Aarti Industries Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Stock return of Aarti Industries Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 12.8% based on the current price.

DeciZen - make an informed investing decision on Aarti Inds

Based on:

Data
Research

Consolidated basis

1. Right Stock

2. Right Price

Price Chart

3. Right Time ⓘ

#Likely Future 5 Year CAGR.

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Aarti Industries stock performance

Key Ratios

Is Aarti Industries Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	20.7%	19.9%	17%	18.5%	15.9%	13.2%	22%	10.5%	7.3%	6.4%	-
Value Creation Index ⓘ	0.5	0.5	0.3	0.4	0.2	0.2	1.0	-0.2	-0.4	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3,007	3,163	3,806	4,168	4,186	4,506	6,086	6,619	6,371	7,271	8,045
Sales YoY Gr.	-	5.2%	20.3%	9.5%	0.5%	7.6%	35.1%	8.8%	-3.7%	14.1%	-
Adj EPS ⓘ	7.7	9.6	10.1	14.2	15.2	15	32.7	15	11.5	9.2	10.4
YoY Gr.	-	24.7%	5.2%	40.1%	7.5%	-1.3%	117.7%	-54%	-23.5%	-20.2%	-
BVPS (₹) ⓘ	34.1	41.5	48.5	75.9	85.5	100.5	124.6	135.7	145.9	154.4	161.2
Adj Net Profit ⓘ	257	315	329	491	530	523	1,185	545	417	333	378
Cash Flow from Ops. ⓘ	574	470	335	736	1,102	873	519	1,319	1,210	1,242	-
Debt/CF from Ops. ⓘ	2.3	3.3	6.2	3.3	1.9	3.3	5	2.2	3	3.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.3%	11.7%	6.1%	14.1%
Adj EPS ⓘ	2%	-9.6%	-34.5%	-20.2%
BVPSⓘ	18.3%	12.6%	7.4%	5.8%
Share Price	12.5%	-9.2%	-7.2%	10.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	23.8	25.2	22.3	23.3	18.9	16.1	29.6	11.6	8.2	6.1	6.6
Op. Profit Mgn % ⓘ	19	20.7	18.4	23.2	23.4	21.8	28.3	16.5	15.4	13.8	13.7
Net Profit Mgn % ⓘ	8.9	10.3	9	12.1	12.9	11.9	19.5	8.2	6.5	4.6	4.7
Debt to Equity ⓘ	1.1	1.2	1.3	0.9	0.7	0.8	0.6	0.6	0.7	0.7	-
Working Cap Days ⓘ	179	161	160	153	168	161	132	126	127	119	67
Cash Conv. Cycle ⓘ	81	80	83	80	90	75	64	82	74	42	-16

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	10.3	10.4
TTM Sales (₹ Cr.)	7,988	8,045
BVPS (₹) ⓘ	161.5	161.2
Reserves (₹ Cr.) ⓘ	5,673	5,664
P/BV ⓘ	2.73	2.73
PE ⓘ	42.61	42.27

From the Market
52 Week Low / High (₹)	338.20 / 494.00
All Time Low / High (₹)	0.64 / 1168.40
Market Cap (₹ Cr.)	15,980
Equity (₹ Cr.)	181.3
Face Value (₹)	5
Industry PE ⓘ	45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

2.38

3.68

3.79

3.85

3.55

3.56

3.57

* Pledged shares as % of Promoter's holding (%)

Valuation of Aarti Inds - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	3,007	3,163	3,806	4,168	4,186	4,506	6,086	6,619	6,371	7,271
Operating Expenses ⓘ +	2,434	2,510	3,107	3,202	3,209	3,525	4,365	5,530	5,397	6,274
Manufacturing Costs	568	644	790	862	918	1,063	1,210	1,425	1,157	1,144
Material Costs	1,573	1,536	1,901	1,848	1,757	1,801	2,389	3,261	3,485	4,221
Employee Cost	121	152	190	243	305	371	357	385	404	422
Other Costs ⓘ	173	178	226	250	229	289	409	459	351	487
Operating Profit ⓘ	572	654	699	965	977	982	1,720	1,089	974	997
Operating Profit Margin (%)	19.0%	20.7%	18.4%	23.2%	23.3%	21.8%	28.3%	16.5%	15.3%	13.7%
Other Income ⓘ +	6	2	8	2	9	1	1	1	11	18
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	2
Interest ⓘ	117	117	132	183	125	86	102	168	211	275
Depreciation ⓘ	99	123	146	163	185	231	246	310	378	434
Profit Before Tax ⓘ	363	416	429	622	676	665	1,372	611	395	307
Tax ⓘ	95	88	83	118	129	129	186	66	-21	-24
Profit After Tax	268	328	346	504	547	535	1,186	545	416	331
PAT Margin (%)	8.9%	10.4%	9.1%	12.1%	13.1%	11.9%	19.5%	8.2%	6.5%	4.6%
Adjusted EPS (₹)	7.7	9.6	10.2	14.2	15.4	15.0	32.7	15.0	11.5	9.1
Dividend Payout Ratio (%)	28%	3%	2%	19%	11%	10%	11%	17%	9%	11%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1,137	1,362	1,578	2,631	2,979	3,503	4,516	4,920	5,287	5,597
Share Capital ⓘ	42	41	41	43	87	87	181	181	181	181
Reserves ⓘ	1,096	1,321	1,538	2,587	2,892	3,416	4,335	4,739	5,106	5,415
Debt +	1,233	1,436	1,921	2,106	1,811	2,492	2,208	2,520	3,095	3,549
Long Term Debt	527	596	908	815	581	1,268	930	635	1,524	1,867
Short Term Debt	706	839	1,012	1,291	1,230	1,224	1,278	1,885	1,571	1,682
Minority Interest	52	64	77	84	95	12	1	1	1	0
Trade Payables	305	300	357	279	345	576	345	216	725	1,237
Others Liabilities ⓘ	239	337	458	759	1,103	1,058	753	872	864	512
Total Liabilities ⓘ	2,966	3,499	4,391	5,858	6,333	7,642	7,823	8,528	9,972	10,896
Fixed Assets
Net Fixed Assets ⓘ +	1,246	1,697	1,998	2,147	2,468	3,593	3,595	4,861	5,649	6,377
Gross Block	2,081	2,655	3,101	3,362	3,837	5,155	5,005	6,306	7,291	8,428
Accumulated Depreciation	835	958	1,103	1,215	1,369	1,563	1,410	1,445	1,642	2,051
CWIP ⓘ	313	270	436	795	1,418	1,298	1,346	1,096	1,229	1,454
Investments ⓘ	41	47	47	33	37	64	28	17	23	48
Inventories	495	571	747	772	836	936	934	1,031	1,160	1,454
Trade Receivables	523	525	655	776	753	794	1,092	940	854	786
Cash Equivalents	29	29	32	804	247	412	174	201	516	295
Others Assets ⓘ	319	361	476	532	573	546	655	382	540	482
Total Assets ⓘ	2,966	3,499	4,391	5,858	6,333	7,642	7,823	8,528	9,972	10,896

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	574	470	335	736	1,102	873	519	1,319	1,210	1,242
PBT ⓘ	363	416	429	622	676	665	1,372	611	395	305
Adjustment ⓘ	212	239	268	344	300	312	348	478	577	700
Changes in Working Capital ⓘ	96	-87	-263	-99	290	-7	-955	321	323	230
Tax Paid ⓘ	-98	-97	-99	-131	-164	-97	-246	-91	-86	7
Cash Flow From Investing Activity ⓘ +	-452	-529	-610	-797	-1,124	-1,322	-1,169	-1,330	-1,369	-1,398
Capex	-450	-530	-614	-791	-1,126	-1,314	-1,165	-1,326	-1,306	-1,379
Net Investments	-4	1	3	-6	-3	-8	-5	-4	-16	-26
Others ⓘ	2	0	0	0	4	0	1	0	-48	7
Cash Flow From Financing Activity ⓘ +	-128	58	279	833	-535	614	412	38	420	-73
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	1,187	0	0	0
Net Proceeds from Borrowing ⓘ	31	139	346	40	-242	752	-595	-301	889	138
Interest Paid ⓘ	-117	-117	-132	-183	-125	-86	-102	-168	-211	-275
Dividend Paid ⓘ	-95	-1	-10	-44	-106	-45	-127	-91	-54	-36
Others ⓘ	53	37	75	1,020	-62	-6	49	598	-203	101
Net Cash Flow ⓘ	-7	-0	4	772	-557	165	-239	27	261	-229

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	24.91	26.22	23.55	23.96	19.5	16.52	29.58	11.56	8.16	6.08
ROCE (%)	20.65	19.91	17.02	18.51	15.85	13.15	21.96	10.48	7.29	6.39
Asset Turnover Ratio	1.02	0.98	0.96	0.92	0.76	0.72	0.89	0.89	0.76	0.77
PAT to CFO Conversion(x)	2.14	1.43	0.97	1.46	2.01	1.63	0.44	2.42	2.91	3.75
Working Capital Days
Receivable Days	58	60	57	55	60	56	50	51	47	37
Inventory Days	64	62	63	59	63	64	50	49	57	59
Payable Days	64	72	63	63	65	93	70	31	49	85

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarti Industries Ltd FAQs

The current trading price of Aarti Inds on 17-Apr-2026 16:59 is ₹440.7.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Aarti Inds stood at ₹15,979.5 Cr

The latest P/E ratio of Aarti Inds as of 16-Apr-2026 is 42.61.

The latest P/B ratio of Aarti Inds as of 16-Apr-2026 is 2.73.

The 52-week high of Aarti Inds is ₹494.0 and the 52-week low is ₹338.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Inds is ₹7,988 ( Cr.) .

About Aarti Industries Ltd

Aarti Industries Limited is listed entity incorporated in India. Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals manufactured by the company are used in the downstream manufacture of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes, etc.

Business area of the company

Aarti Industries is engaged in manufacturing and dealing in speciality chemicals and pharmaceuticals.

Products offered by the company

Chemical products

Chlorination
Nitration
Hydrogenation
Ammonolysis
Halex
Dinitro chlorination
Alkylation
Hydrolysis
Methoxylation
Esterification
Diazaotiation
Sulphonation
Condensation
N-Alkylation
Oxidation
Other (inorganic)

Pharma

Anti Hypertensive

Ramipril
Quinapril HCL
Benazepril HCL
Benazepril HCL Polymorph B
Perindopril Tert-butylamine
Perindopril Arginine
Ranolazine Di-HCL / Base

Anti Asthamatic

Budesonide
Bambuterol HCL
Salmeterol Xinafoate
Ipratropium Bromide
Ciclesonide
Fluticasone Propionate
Fluticasone Furoate
Mometasone Furoate Monohydrate
Formoterol Fumarate
Montelukast Sodium

Anti Cancer

Bicalutamide
Ifosfamide
Ifosfamide Sterile
Cyclophosphamide
Cyclophosphamide Sterile
Mesna
Mercaptopurine
Azathioprine
Capecitabine
R-Salbutamol Sulphate
Levalbuterol HCL
Levalbuterol Tartrate

Milestones

1984

Incorporated Aarti Organics Private Limited.

1986

Commenced 1,200 Tonnes Per Annum (TPA) unit for Nitro Chloro Benzenes (NCB) in Sarigram, Gujarat.

1990

Set up the first large-scale organic plant in Vapi - 4,500 TPA unit for NCB.

2001

Set up a large-scale hydrogenation and nitration unit at Jhagadia (hydrogen gas via pipeline).

2005-08

Expanded the NCB and sulphuric acid capacity.
Set up a large-scale speciality chemical unit in Kutch.
Received US FDA approval for an Active Pharmaceutical Ingredient (API) unit in Tarapur.

2011

Upgraded the hydrogenation unit from batch to continuous.
Received USFDA approval for the custom synthesis division at Vapi.
Commenced bulk shipment for global markets.

2016

Commissioned an ethylation facility at Dahej SEZ (ethylene gas via pipeline).
Expanded the NCB capacity from 57 KTPA to 75 KTPA.

2017

Commenced the functioning of the calcium chloride facility.
Started operations at co-generation and solar power plants.

2018

Commissioned the Nitro Toulene plant.
Signed two large multi-year contracts with global players.
Manufacturing facility being set up at Dahej SEZ.

2019

Commissioned the Nitro Toulene hydrogenation facility at Jhagadia.
Signed another multi-year contract with a global player.

2020

Operationalised Aarti Research and Technology Centre (ARTC) at Mahape, Navi Mumbai.
Commissioned two units at Dahej SEZ for high-value speciality chemicals.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Aarti Industries Ltd (AARTIIND) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Aarti Inds Share Price